Drugs for metabolic conditions and prostate cancer death in men on GnRH agonists

E-ISSN： 1464-410x|121|2|260-267

ISSN： 1464-4096

Source： BJU INTERNATIONAL, Vol.121, Iss.2, 2018-02, pp. : 260-267

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Quality of Life in Patients with Prostate Cancer Treated with LH-RH Agonists

Current Urology, Vol. 2, Iss. 1, 2008-08 ,pp. : 30-35

Karger

Access to resources Recommend Favorite

Gonadotropin-Releasing Hormone (GnRH) and GnRH Receptor in Bladder Cancer Epithelia and GnRH Effect on Bladder Cancer Cell Proliferation

Urologia Internationalis, Vol. 80, Iss. 4, 2008-06 ,pp. : 431-438

Karger

Access to resources Recommend Favorite

Androgen deprivation therapy and the risk of death from prostate cancer among men with favorable or unfavorable intermediate‐risk disease

CANCER, Vol. 121, Iss. 16, 2015-08 ,pp. : 2713-2719

John Wiley & Sons Inc

Access to resources Recommend Favorite

Climacteric-Like Disorders in Prostate Cancer Patients Treated With LHRH Agonists

By Nishimura K. Yamaguchi Y. Yamanaka M. Ichikawa Y. Nagano S.

Archives of Andrology, Vol. 51, Iss. 1, 2005-01 ,pp. : 41-48

Informa Healthcare

Access to resources Recommend Favorite

By Kazanis Maryanne Smith Matthew

Clinical Review in Bone and Mineral Metabolism, Vol. 2, Iss. 2, 2004-06 ,pp. : 115-122

Humana Press, Inc

Access to resources Recommend Favorite